Escalon Medical Corp.
ESMC
$0.2922
-$0.0015-0.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.95M | 12.17M | 11.82M | 11.98M | 11.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.95M | 12.17M | 11.82M | 11.98M | 11.65M |
| Cost of Revenue | 7.09M | 6.79M | 6.75M | 6.84M | 6.51M |
| Gross Profit | 5.86M | 5.38M | 5.06M | 5.15M | 5.13M |
| SG&A Expenses | 4.58M | 4.54M | 4.56M | 4.56M | 4.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.30M | 11.96M | 11.93M | 12.09M | 11.68M |
| Operating Income | 643.20K | 210.60K | -115.80K | -104.40K | -37.80K |
| Income Before Tax | 619.70K | 186.10K | -136.20K | -125.20K | -61.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.62 | 0.19 | -0.14 | -0.13 | -0.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 619.70K | 186.10K | -136.20K | -125.20K | -61.20K |
| EBIT | 643.20K | 210.60K | -115.80K | -104.40K | -37.80K |
| EBITDA | 691.90K | 254.10K | -70.10K | -58.40K | -300.00 |
| EPS Basic | 0.05 | 0.00 | -0.03 | -0.02 | -0.04 |
| Normalized Basic EPS | 0.05 | 0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.04 | 0.00 | -0.03 | -0.02 | -0.04 |
| Normalized Diluted EPS | 0.03 | 0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 29.66M | 29.66M | 29.66M | 29.66M | 29.66M |
| Average Diluted Shares Outstanding | 43.08M | 36.33M | 29.66M | 29.66M | 36.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |